Patients should be offered a &34;menu" of options regarding what level of discussion takes place prior to cataract surgery.
Patients should be offered a "menu" of options regarding what level of discussion takes place prior to cataract surgery, according to Michael Austin and co-workers from two hospitals in South West Wales, UK.
One hundred consecutive patients were asked preliminary questions to determine their risk perception and knowledge of cataract surgery together with the level of information they wanted prior to giving their consent. Those who proceeded were shown a narrated PowerPoint presentation that was designed to both educate and act as a standardized questionnaire. Every patient was asked to rate each component of the presentation for its relevance to their ability to give informed consent.
Of the 100 patients questioned, 95% knew that cataract surgery involves an element of risk, however 32% did not wish to know anything about the risks and would prefer to leave the decisions to their ophthalmologist. Twenty-two percent were only interest in knowing their overall chance of visual improvement. The remaining 46% welcomed discussion about the possible complications.
Of the 25 patients who completed the whole presentation, 18 wanted to know about PC tearing, 17 about endophthalmitis, 16 about dropped lens, retinal detachment and corneal clouding and 15 wanted to know about bleeding, sympathetic ophthalmia and posterior capsular opacification.
The researchers concluded that patients differ quite widely in what level of information they want before giving informed consent so recommend offering a "menu" of choices for the patient to pick from.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
2 Commerce Drive
Cranbury, NJ 08512